Friday, November 20, 2026

Medical Ethics in Medical Research & Scientific Ambition

When Scientific Ambition Meets Medical Ethics - My Reflections as a Former Medical Researcher

I recently read an alarming report in Malay Mail, dated 18 November 2026, concerning a Chinese neuroscientist, Zilong Qiu, who was dismissed from his position and suspended from participating in scientific projects for five years following a government investigation into the death of a six-year-old girl during an experimental gene-editing treatment.

Read the story here:

https://www.malaymail.com/news/life/2026/11/18/chinese-scientist-loses-job-gets-five-year-research-ban-over-girls-death-in-gene-editing-trial/24365


The child suffered from Snijders Blok-Campeau syndrome, a very rare neurodevelomental disorder. It is a genetic disorder caused by the mutation in a single gene called CD3. Although it is a genetic condition, it rarely runs in families. Most cases result from a new (de novo) spontaneous mutation that occurs randomly during the formation of an egg or sperm, or in early embryonic development  

According to the report, she died in March 2025 from complications following experimental gene therapy intended to correct her condition. More disturbing was the finding that her death had not been disclosed in a scientific paper published in Nature. The investigation also raised questions about whether her parents had been adequately informed of the potential risks and whether relevant safety concerns from earlier experiments involving primates had been properly communicated.

The report stated that the child's parents had paid more than US$800,000 to fund the experimental treatment.

This incident brought back memories of my own experience in medical research in Malaysia many years ago. Although my work was conducted under a very different research environment and involved different scientific procedures, I remember vividly how seriously we had to approach the ethical responsibilities associated with conducting research involving human subjects.

During my service at the Institute for Medical Research (IMR), I was involved in numerous research studies - just to name one of them (as an example) was a clinical study I undertook to evaluate the effects of a palm oil based diet on plasma lipoproteins and thrombogenicities where I was leading a large team of doctors and scientists. In most of these studies involving human subjects I have to obtain approval from the medical research ethics committee before we could proceed with our proposed study. I remember that the committee was a formidable panel comprising approximately 30 members, almost all of them medical specialists in various fields  and, interestingly, included the Attorney-General, who was the chief legal adviser to the Malaysian Government.

The Attorney-General's presence was particularly significant because our research was a government-funded project conducted by IMR, which was itself a government department, and the researchers, including myself, were government employees. His involvement provided an important legal dimension to the committee's deliberations. Apart from examining the medical and ethical acceptability of the proposed investigation, it was necessary to ensure that the procedures, consent arrangements, responsibilities and safeguards were consistent with the applicable legal requirements.

This was important not only for the protection of the human volunteers participating in the study, but also for ensuring that the researchers, IMR and the Government discharged their respective responsibilities appropriately. In the unfortunate event of a death, injury or other mishap involving a participant, questions of legal responsibility and possible claims against the individuals and institutions involved could arise. The committee therefore had to consider these potential implications before permitting the research to proceed.

I came to appreciate that human medical research is not solely a scientific or medical undertaking. It also carries considerable ethical, administrative and legal responsibilities, particularly when public funds and government institutions are involved.

I was summoned before this committee on two separate occasions. Each time, I had to face prolonged questioning lasting several hours. I was required to explain in considerable detail the objectives and scientific justification of our research, the methodology we intended to employ, the selection of our study subjects, the procedures involved and, most importantly, the possible risks and ethical implications.

What made the experience particularly interesting was that some of the committee members were people I knew personally. One was my own Director at IMR, who only a few months earlier had encouraged me to lead the research project. Another member sitting in the huge medical ethics committee was a close personal friend of mine, a Senior Consultant Psychiatrist and Head of the Department of Psychological Medicine at the University Teaching Hospital, University of Malaya. We already knew each other decades ago when we were together during our college days and we were still very close with each other even after we started working - he at the University Teaching Hospital, University of Malaya, and myself at the Institute for Medical Research. 

Despite these personal and professional relationships, I had to face them as an investigator seeking ethical approval, not as colleagues or friends. Their responsibility was to scrutinize my proposed research independently, and mine was to satisfy them that the study was scientifically justified and ethically acceptable.

Our study subjects were medical and medical technology students. Before involving them in the research, my Deputy Director and I made sure that we explained the purpose and nature of the investigation, what their participation would involve, the possible risks and the restrictions they would need to observe throughout the study.

We did not merely distribute consent forms and ask them to sign. We held lengthy explanatory sessions, followed by question-and-answer discussions, to ensure that they understood what they were agreeing to. They were given opportunities to raise questions and clarify any uncertainties before deciding whether to participate. Only those who voluntarily agreed were enrolled and asked to sign the appropriate informed consent forms.

However, my responsibilities did not end once the participants had agreed to take part in the research. Their health and safety remained our responsibility throughout the investigation.

I was also tasked with providing medical attention should any participant become ill during the study. This introduced another layer of complexity because any illness or treatment had to be carefully assessed to ensure that it would not interfere with the experimental procedures or compromise the scientific validity of our investigation. If a volunteer fell sick, we could not use drugs to treat them because drugs will interfere with the results due to drug-nutrient interactions or drugs interfering with biochemical or other pathological pathways. We then consulted a pharmacologist who told us no drug to be used in such a study. So, what shall we do if a participant fell sick? Fortunately I have an additional postgraduate degree in natural (naturopathic) medicine and have a license to practice. 

 I was then tasked by the Director of IMR to treat them using non-drug approaches.  Additionally, my Deputy Director, Dr. Khalid Hassan was also a highly qualified specialist physician and a haematologist who was also involved in the study. Together, both of us took the responsibility of taking care of the sick.   Both of us  were  then given a pager (beeper) each by the IMR and we needed to wear it day and night everywhere in case one of the participants fell sick and we have to be called up. There was  no handphone or smart phone then, only pagers or beepers. Pagers were widely used from 1950s through the 1990s especially well into the late 1990s before mobile phones replaced them. Pagers are still used today in hospitals and in emergency services because of their reliability. 

Fortunately no one fell sick throughout the year-long study.   

If a participant's medical condition or treatment meant that continued participation was no longer appropriate, we had to consider withdrawing that individual from the study for safety reasons. Naturally, this could affect our original sampling numbers and sampling size and potentially influence the statistical power and interpretation of our findings.

Consequently, such circumstances also required consultation with our bio-statistician, who was an integral member of the research team. We had to consider the statistical implications of any changes to the study population and ensure that our research conclusions would remain scientifically valid.

Looking back, I realize that our research involved far more than the actual collection of data and the subsequent analysis of results. The preparation alone took several months, involving endless meetings and discussions among colleagues, medical and scientific  specialists and, at times, the study participants themselves. Every aspect of the investigation had to be carefully considered, discussed and settled before we could proceed. There were other studies where I was also involved, and for all of them we have to follow same procedures and protocols. 

I mention these details because people who have never been involved in human medical research may not appreciate how demanding and complicated the process can be. It is not simply a matter of having an interesting scientific hypothesis, a competent research team, adequate funding and sophisticated laboratory facilities. There are numerous ethical, medical, scientific, legal and administrative considerations that must be addressed before a single human subject is recruited.

I came to appreciate that obtaining a signature on a consent form was not simply an administrative formality. The participants had to understand the nature of the research, its procedures and foreseeable risks. They also needed to know that their participation was voluntary and that they could decline or withdraw without being penalized.

The protection of human life and dignity must always come before the pursuit of scientific recognition.

I believe this responsibility becomes even greater when research involves children, particularly those who suffer from rare diseases and whose parents are desperately hoping for a cure. Such parents may be prepared to accept considerable risks because they want to give their children a better future. Their desperation and hope must never be mistaken for an unrestricted licence to experiment.

Children cannot always understand the nature of experimental medical interventions or appreciate their potential consequences. Consequently, investigators and ethics committees must exercise an exceptionally high degree of caution. Parental permission is essential, but it does not remove the researcher's responsibility to establish that the proposed intervention is scientifically justified, that its risks are proportionate to its anticipated benefits and that all reasonable safeguards are in place. Where appropriate, the child's own willingness or assent should also be considered.

In the case reported in China, I am particularly concerned about the apparent failure to disclose the child's death in the published research. A scientific publication is not merely a means of communicating successful results or establishing the reputation of its authors. It is also an essential record of what actually happened during an investigation, including unexpected complications, adverse events and unsuccessful outcomes.

Science advances not only through success but also through the honest reporting of failure. Indeed, an adverse outcome may provide information that is even more important for protecting future patients than a successful experiment. Concealing such information undermines the very foundation upon which scientific knowledge is built.

A researcher must therefore be accountable not only to the institution employing him or her, but also to the research participants, their families, the scientific community and society at large.

Another important consideration is the distinction between scientific innovation and clinical responsibility. Gene-editing technology holds tremendous promise for treating inherited diseases and conditions that were previously considered untreatable. However, the ability to manipulate genetic material does not automatically mean that every proposed intervention is sufficiently safe or ready for use in human beings.

The more powerful our scientific tools become, the greater our responsibility to understand their limitations and possible unintended consequences. Previous laboratory and animal studies, independent safety assessments, appropriate regulatory approvals and carefully monitored clinical investigations are essential components of responsible scientific progress.

I do not believe that this unfortunate incident should be interpreted as a reason to discourage scientific research or biotechnology development in China, or anywhere else in the world. China, like other countries, has made considerable investments in biomedical science, and its scientists have every right to pursue new discoveries. However, the ambition to become a global leader in biotechnology must go hand in hand with transparency, accountability and respect for human life.

Scientific excellence cannot be measured solely by the number of research publications, patents, technological breakthroughs or international awards. It must also be measured by the integrity of the people conducting the research and the care with which they protect those who place their trust in them.

I also believe that an ethics committee must be genuinely independent. Its purpose is not to facilitate the ambitions of a research director, satisfy the expectations of an institution or accelerate a promising scientific project. Its responsibility is to protect research participants, even if this means questioning, delaying, modifying or rejecting a proposal supported by influential scientists or senior administrators.

My own experience at IMR taught me that even when a research project has the encouragement of one's Director and the support of colleagues, the investigator must still be prepared to defend every aspect of the proposed study before an independent ethics committee. Personal relationships, professional seniority and scientific enthusiasm should never exempt anyone from such scrutiny.

My experience also taught me that the responsibilities of a principal investigator do not stop when ethical approval is granted. They continue throughout the entire investigation. Every participant must be treated as an individual whose welfare matters, not merely as a source of data or a number contributing to the required sample size. Scientific protocols must be followed, but they must never take precedence over appropriate medical care and the safety of the people involved.

As I reflect on this incident, I am grateful that I am now retired from the demanding responsibilities of medical research. I remember the long hours spent preparing research proposals, answering difficult questions, organizing study subjects, consulting colleagues and biostatisticians, and ensuring that the necessary ethical and administrative requirements were fulfilled. At the time, these procedures sometimes seemed exhausting, but I now appreciate their importance even more.

I have always believed that scientific research should serve humanity. Our discoveries should improve the quality of life, alleviate suffering and expand our understanding of the natural world. But in pursuing these noble objectives, we must never forget that the people who participate in our research are not merely experimental subjects, statistical observations or stepping stones towards a scientific breakthrough. They are human beings with lives, families, hopes and dignity.

A scientific breakthrough may bring honour to a researcher, an institution or to an entire nation, especially if a medical researcher can win the  Nobel Prize in medicine or in physiology. That indeed  is extremely prestigious and glamourous - a very glittering  crown for the individual and the nation indeed. Unfortunately, a Nobel Prize in medicine or in physiology is exceedingly difficult to win for most medical scientists - the lest of all for clinicians and medical doctors. See here the reasons: 

Nobel Prizes in Medicine: Are Clinicians out of Fashion?”


https://scientificlogic.blogspot.com/search?q=clinicians+out+of+fashion+for+nobel+prize

Even an ordinary scientific breakthrough may bring honour to a researcher, an institution or an entire nation the most prestige. But no scientific achievement can justify sacrificing the ethical principles that are supposed to guide scientific progress.

Perhaps the most important lesson I have taken from my years in medical research is this: we may have immense scientific knowledge and technological ability to conduct an experiment, but that does not necessarily mean that we have the ethical justification to do so.

Scientific progress tells us what we can do. Medical ethics reminds us what we should do, what we should not do and, sometimes, when we must have the courage to stop.

Lim Ju Boo
Former Medical Researcher
Institute for Medical Research (IMR), Malaysia

 

References

 

1. World Medical Association. (2024). Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Participants. World Medical Association.

2. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1979). The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. United States Department of Health and Human Services.

3. Council for International Organizations of Medical Sciences (CIOMS). (2016). International Ethical Guidelines for Health-related Research Involving Humans. Geneva: CIOMS.

4. Malay Mail. (18 November 2026). Chinese scientist loses job, gets five-year research ban over girl's death in gene-editing trial.

No comments:

Medical Ethics in Medical Research & Scientific Ambition

When Scientific Ambition Meets Medical Ethics - My Reflections as a Former Medical Researcher I recently read an alarming report in Malay Ma...